Tag: Chemotherapy
Addition of Cetuximab to CRT Cuts Locoregional Failure in Anal CA
Findings in patients with stage I to III squamous cell carcinoma of the anal canal
Worsening QoL Linked to Early Tx Discontinuation in Breast Cancer
Worsening in any MENQOL domain or menopause-specific QoL linked to early treatment cessation
Chemo Benefits Patients After Nephroureterectomy in UTUC
Adjuvant chemo better than observation after radical nephroureterectomy for upper tract urothelial CA
Delayed Chemo After Surgery Still Beneficial in Lung Cancer
Patient recovery may mean longer time to chemotherapy, but treatment can still have benefit
More Cognitive Difficulties for Patients After Chemotherapy
Breast cancer survivors report cognitive issues after chemo, through six-month follow-up
Optimal Timing ID’d for Flu Shot During Three-Week Chemo Cycle
Comparable antibody responses for influenza vaccination on day one or 11 of chemo cycle
Adjuvant Chemo Plus CRT Best in Nasopharyngeal Carcinoma
Highest survival benefit for addition of AC to CRT, with consistent improvement for all end points
Chemo-Related Cardiotoxicity Worse in Diabetes Patients
Those with diabetes showed more early warning signs of heart failure
SIOP Scale Best for Detecting Ototoxicity With Cisplatin Tx
Findings show superiority for SIOP in pediatric patients with planned cisplatin-containing treatment
Cetuximab + Chemoradiation Can Cure HIV-Associated Anal Cancer
Addition of cetuximab may result in less locoregional failure for squamous cell carcinoma of anal canal
